Income Statement
12 months ended: | Net product sales | Operating income (loss) | Net income (loss) attributable to Celgene |
---|---|---|---|
Dec 31, 2018 | 15,265) | 5,191) | 4,046) |
Dec 31, 2017 | 12,973) | 4,707) | 2,940) |
Dec 31, 2016 | 11,185) | 3,167) | 1,999) |
Dec 31, 2015 | 9,161) | 2,255) | 1,602) |
Dec 31, 2014 | 7,564) | 2,519) | 2,000) |
Dec 31, 2013 | 6,362) | 1,809) | 1,450) |
Dec 31, 2012 | 5,386) | 1,746) | 1,456) |
Dec 31, 2011 | 4,700) | 1,443) | 1,318) |
Dec 31, 2010 | 3,508) | 990) | 881) |
Dec 31, 2009 | 2,567) | 842) | 777) |
Dec 31, 2008 | 2,138) | (1,464) | (1,534) |
Dec 31, 2007 | 1,300) | 425) | 226) |
Dec 31, 2006 | 812) | 175) | 69) |
Dec 31, 2005 | 446) | 84) | 64) |
Based on: 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Balance Sheet: Assets
Current assets | Total assets | |
---|---|---|
Dec 31, 2018 | 9,067) | 35,480) |
Dec 31, 2017 | 14,892) | 30,141) |
Dec 31, 2016 | 10,868) | 28,086) |
Dec 31, 2015 | 9,401) | 27,053) |
Dec 31, 2014 | 9,713) | 17,340) |
Dec 31, 2013 | 7,551) | 13,378) |
Dec 31, 2012 | 5,534) | 11,734) |
Dec 31, 2011 | 4,353) | 10,006) |
Dec 31, 2010 | 4,343) | 10,177) |
Dec 31, 2009 | 3,845) | 5,389) |
Dec 31, 2008 | 2,841) | 4,445) |
Dec 31, 2007 | 3,084) | 3,611) |
Dec 31, 2006 | 2,311) | 2,736) |
Dec 31, 2005 | 973) | 1,247) |
Based on: 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Balance Sheet: Liabilities and Stockholders’ Equity
Celgene Corp., selected items from liabilities and stockholders’ equity, long-term trends
US$ in millions
Current liabilities | Total liabilities | Total debt | Stockholders’ equity | |
---|---|---|---|---|
Dec 31, 2018 | 4,057) | 29,319) | 20,270) | 6,161) |
Dec 31, 2017 | 2,987) | 23,220) | 15,838) | 6,921) |
Dec 31, 2016 | 2,959) | 21,486) | 14,289) | 6,599) |
Dec 31, 2015 | 1,969) | 21,134) | 14,250) | 5,919) |
Dec 31, 2014 | 2,112) | 10,815) | 6,872) | 6,525) |
Dec 31, 2013 | 1,946) | 7,788) | 4,741) | 5,590) |
Dec 31, 2012 | 1,690) | 6,040) | 3,080) | 5,694) |
Dec 31, 2011 | 1,540) | 4,493) | 1,802) | 5,513) |
Dec 31, 2010 | 1,070) | 4,182) | 1,248) | 5,984) |
Dec 31, 2009 | 495) | 995) | —) | 4,395) |
Dec 31, 2008 | 527) | 954) | —) | 3,491) |
Dec 31, 2007 | 433) | 767) | 197) | 2,844) |
Dec 31, 2006 | 240) | 760) | 400) | 1,976) |
Dec 31, 2005 | 136) | 611) | 400) | 636) |
Based on: 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Cash Flow Statement
12 months ended: | Net cash provided by operating activities | Net cash (used in) provided by investing activities | Net cash provided by (used in) financing activities |
---|---|---|---|
Dec 31, 2018 | 5,171) | (6,418) | (1,540) |
Dec 31, 2017 | 5,246) | (2,891) | (1,584) |
Dec 31, 2016 | 3,976) | (1,002) | (1,646) |
Dec 31, 2015 | 2,484) | (6,259) | 4,585) |
Dec 31, 2014 | 2,806) | (1,438) | (417) |
Dec 31, 2013 | 2,226) | (529) | (554) |
Dec 31, 2012 | 2,019) | (1,554) | (249) |
Dec 31, 2011 | 1,809) | 378) | (1,655) |
Dec 31, 2010 | 1,182) | (2,107) | 1,177) |
Dec 31, 2009 | 910) | (856) | (62) |
Dec 31, 2008 | 182) | (522) | 282) |
Dec 31, 2007 | 478) | (990) | 288) |
Dec 31, 2006 | 84) | 7) | 1,221) |
Dec 31, 2005 | 42) | (103) | 53) |
Based on: 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Per Share Data
12 months ended: | Basic earnings per share 1 | Diluted earnings per share 2 | Dividend per share 3 |
---|---|---|---|
Dec 31, 2018 | 5.65 | 5.51 | 0.00 |
Dec 31, 2017 | 3.77 | 3.64 | 0.00 |
Dec 31, 2016 | 2.57 | 2.49 | 0.00 |
Dec 31, 2015 | 2.02 | 1.94 | 0.00 |
Dec 31, 2014 | 2.49 | 2.39 | 0.00 |
Dec 31, 2013 | 1.75 | 1.69 | 0.00 |
Dec 31, 2012 | 1.69 | 1.65 | 0.00 |
Dec 31, 2011 | 1.45 | 1.43 | 0.00 |
Dec 31, 2010 | 0.95 | 0.94 | 0.00 |
Dec 31, 2009 | 0.85 | 0.83 | 0.00 |
Dec 31, 2008 | -1.73 | -1.73 | 0.00 |
Dec 31, 2007 | 0.30 | 0.27 | 0.00 |
Dec 31, 2006 | 0.10 | 0.09 | 0.00 |
Dec 31, 2005 | 0.10 | 0.09 | 0.00 |
Based on: 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
1, 2, 3 Data adjusted for splits and stock dividends.